baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Nexi SpA/ IT0005366767 /

23/05/2024 16:36:40	Chg. -0.03	Volume	Bid16:37:04	Ask16:37:04	Market Capitalization	Dividend Y.	P/E Ratio
6.10EUR	-0.51%	489,391 Turnover: 1.24 mill.	6.10Bid Size: 4,990	6.10Ask Size: 1,782	8 bill.EUR	-	-

GlobeNewswire 24/10/2023 NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes

GlobeNewswire 19/10/2023 NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting

GlobeNewswire 18/10/2023 NexImmune Announces 1-for-25 Reverse Stock Split

GlobeNewswire 29/09/2023 Calian Launches Digital Health Portfolio of Products and Services

GlobeNewswire 28/09/2023 Northland Power Announces Financial Close of the 1.0 GW Hai Long Offshore Wind Project in Taiwan Fin...

GlobeNewswire 31/08/2023 NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development ...

GlobeNewswire 17/03/2022 NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Valida...

GlobeNewswire 14/03/2022 NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center

GlobeNewswire 10/03/2022 NexImmune to Present at the Barclays 2022 Global Healthcare Conference

GlobeNewswire 09/03/2022 NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates

GlobeNewswire 17/02/2022 NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors

GlobeNewswire 05/01/2022 NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board

GlobeNewswire 12/12/2021 NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma

GlobeNewswire 12/11/2021 NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates

GlobeNewswire 08/11/2021 NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November ...

GlobeNewswire 03/11/2021 NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting

GlobeNewswire 20/10/2021 Bottomline Appoints Three New Directors to Board of Directors

GlobeNewswire 27/09/2021 NexImmune to Present at the 2021 Cantor Virtual Global Healthcare Conference

GlobeNewswire 16/09/2021 SBM Offshore completes US$1.6 billion financing of Sepetiba

GlobeNewswire 10/09/2021 NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference

GlobeNewswire 18/08/2021 Aite-Novarica Group Announces Winners of the 2021 Digital Wallet Innovation Awards

GlobeNewswire 09/08/2021 NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates

GlobeNewswire 09/08/2021 NexImmune to Explore the Use of AIM™ Direct Injection Technology in Type 1 Diabetes

GlobeNewswire 27/07/2021 NexImmune to Announce Second Quarter 2021 Financial Results and Provide Corporate Update on August 9...

GlobeNewswire 14/07/2021 NexImmune Strengthens Management Team with Key Appointments

Nexi SpA/ IT0005366767 /

If you wish to receive reply to your feedback, please provide your email address.